Drug interactions
Diethylpropion + Metformin-repaglinide
Severity: Minor
Diethylpropion and Metformin-repaglinide: minor interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Diethylpropion is a sympathomimetic appetite suppressant that can change glucose requirements. Weight loss may improve glycemia and increase hypoglycemia risk, while sympathomimetic effects may transiently raise glucose.
What this interaction means in plain words
Diethylpropion and Metformin-repaglinide have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.
Why it happens
Sympathomimetic effects and weight loss alter insulin sensitivity and glucose levels, affecting antidiabetic requirements.
What to do
Monitor blood glucose when starting or stopping diethylpropion and adjust antidiabetic doses as needed.
What to ask your pharmacist
- Is there anything I should notice while taking both?
- Do I need to tell my doctor at the next visit?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Diethylpropion and Metformin-repaglinide, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Metformin-repaglinide
Frequently asked questions
Can I take Diethylpropion with Metformin-repaglinide?
MediHelp rates the interaction as minor. Diethylpropion and Metformin-repaglinide have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Diethylpropion is a sympathomimetic appetite suppressant that can change glucose requirements. Weight loss may improve glycemia and increase hypoglycemia risk, while sympathomimetic effects may transiently raise glucose.
How serious is the interaction between Diethylpropion and Metformin-repaglinide?
MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood glucose when starting or stopping diethylpropion and adjust antidiabetic doses as needed.
What other medicines interact with Metformin-repaglinide?
MediHelp also lists interactions of Metformin-repaglinide with, for example, Gemfibrozil, Apalutamide, Clarithromycin. The full list is on the Metformin-repaglinide page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
